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To describe the number and treatment of skin and soft
tissue infections likely caused by Staphylococcus aureus in
the United States, we analyzed data from the 1992–1994
and 2001–2003 National Ambulatory Medical Care Surveys
and National Hospital Ambulatory Medical Care Surveys.
Each year, data were reported by an average of 1,400
physicians, 230 outpatient departments, and 390 emer-
gency departments for 30,000, 33,000, and 34,000 visits,
respectively. During 2001–2003, the number of annual
ambulatory care visits for skin and soft tissue infections
was 11.6 million; the visit rate was 410.7 per 10,000 per-
sons. During the study period, rates of overall and physi-
cian office visits did not differ; however, rates of visits to
outpatient and emergency departments increased by 59%
and 31%, respectively. This increase may reflect the emer-
gence of community-acquired methicillin-resistant S.
aureus infections.
S
taphylococcus aureus is the almost-universal cause of
furuncles, carbuncles, and skin abscesses and world-
wide is the most commonly identified agent responsible
for skin and soft tissue infections. S. aureus skin and soft
tissue infections frequently begin as minor boils or
abscesses and may progress to severe infections involving
muscle or bone and may disseminate to the lungs or heart
valves (i.e., endocarditis). Treatment of early infections
consists of incising and draining the lesion, often accom-
panied by β-lactam antimicrobial drugs, which are also
effective against β-hemolytic streptococci.
Strains resistant to β-lactam antimicrobial drugs,
termed methicillin-resistant S. aureus (MRSA), were rec-
ognized from the 1960s through the 1990s as healthcare-
associated (HA) pathogens (1). In the late 1990s, MRSA
disease without established healthcare risk factors, called
community-associated (CA)–MRSA, was increasingly
reported in the literature (2,3). A study conducted in 2004
in emergency departments in 11 US cities found that
MRSA was isolated from 59% of patients with skin and
soft tissue infections (4). The biology of CA-MRSA
appears to differ from that of HA-MRSA and CA–methi-
cillin-susceptible  S. aureus (MSSA), perhaps allowing
CA-MRSA to cause disease other than that expected from
MSSA (5–8). As HA-MRSA emerged, it likely did not
merely replace HA-MSSAbut led to an overall increase in
S. aureus infections in healthcare settings (9–11).
Because most skin and soft tissue infections are treated
in outpatient settings with empiric antimicrobial therapy,
few studies have attempted to estimate the number of S.
aureus skin and soft tissue infections, and none have eval-
uated the antimicrobial drugs prescribed for these condi-
tions. Therefore, with regard to skin and soft tissue
infections likely caused by S. aureus, we 1) estimated the
number and rate of ambulatory care visits in the United
States during 2 periods and examined any changes in these
estimates between these periods; 2) described patient
demographic characteristics; and 3) characterized antimi-
crobial and outpatient surgical therapy provided. Our
results are based on a secondary data analysis of the
1992–1994 and 2001–2003 National Ambulatory Medical
Care Surveys (NAMCS) and National Hospital
Ambulatory Medical Care Surveys (NHAMCS).
Methods
Sample Design 
NAMCS is a probability sample survey of office-based
physicians in the United States, conducted by the National
Center for Health Statistics of the Centers for Disease
Control and Prevention (CDC). The US Bureau of the
Census has been responsible for field operations and data
collection since NAMCS became an annual survey in
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procedures of the NAMCS have been described (12).
NHAMCS is an annual probability sample survey of hos-
pital outpatient departments and emergency departments in
the United States, first conducted in 1992 by CDC’s
National Center for Health Statistics. The US Census
Bureau is responsible for field operations and data collec-
tion. The plan and operation of NHAMCS have been
described (13). 
Response Rates and Sample Size
From 1992 through 2003, response rates were
64%–73% for physician offices, 87%–91% for outpatient
departments, and 90%–97% for emergency departments.
The annual number of participating physicians was
1,000–1,800, outpatient departments 224–283, and emer-
gency departments 364–425. The number of patient record
forms completed each year by physician offices was
24,000–36,000, by outpatient departments 28,000–35,000,
and by emergency departments 26,000–40,000. Estimates
for skin and soft tissue infection visits are based on 3,374
sample records from 1992 through 1994 and 3,941 from
2001 through 2003.
Data Collection and Coding
The same patient record form is used for the physician
office and outpatient department settings, whereas the
emergency department form differs slightly. The patient
record form contains patient demographic data and infor-
mation about the visit, including cause of injury, diagnosis,
ambulatory surgical procedures (NAMCS and NHAMCS
outpatient department), medications, and disposition. As
many as 3 diagnoses are coded according to the
International Classification of Diseases, Ninth Revision,
Clinical Modification (ICD-9-CM) (14). During
2001–2003, 1–3 causes of injury were coded according to
the Supplementary Classification of External Causes of
Injury and Poisoning in the ICD-9-CM, and 1–2 ambulato-
ry surgical procedures were coded to ICD-9-CM volume 3
(14). Cause of injury was not collected on the NAMCS and
outpatient department patient record forms until 1995.
From 1992 through 1994, 1–5 medications were recorded
per visit; this number increased to 6 from 1995 through
2002 and 8 in 2003. Therapeutic classifications were based
on the National Drug Code Directory (15,16). For this
analysis, only 5 drugs per visit were included. A report
describing the method and instruments used to collect and
process drug information has been published (17).
Definitions
Skin and soft tissue infections likely caused by S. aureus
are defined as any diagnoses assigned the ICD-9-CM codes
shown in Table 1. These infections were selected because
of their likelihood of being caused by S. aureus as deter-
mined by the authors and as they appeared in a medical
textbook (18). The ICD-9-CM code for Staphylococcus,
41.1, was not included because it is used as an additional
code to identify the bacterial agent in diseases classified
elsewhere. Few records with this code were found in
NAMCS and NHAMCS data, most likely because cultures
were either not performed or the results were not available
at the time of the visit.
The 1992–1994 denominators used in calculating the
visit rates for age, sex, race, and geographic region are
based on the Census Bureau estimates of the civilian, non-
institutional population of the United States as of July 1,
1992; July 1, 1993; and July 1, 1994, respectively. The
2001–2003 denominators are based on post–Census 2000
estimates of the civilian noninstitutional population of the
United States. Population estimates of metropolitan statis-
tical area status are based on data from the 2001, 2002, and
2003 National Health Interview Surveys, National Center
for Health Statistics, adjusted to the US Census Bureau
definition of core-based statistical areas. Denominators
used to compute estimates of visit rates by expected source
of payment were obtained from the 2001, 2002, and 2003
National Health Interview Surveys. Persons who reported
multiple insurance categories were counted in each catego-
ry reported, with the exception of Medicaid and the State
Children’s Health Insurance Program, which were com-
bined into a single category. Denominator data for type of
insurance were not available for 1992 through 1994.
In the emergency department, “wound care” can be
checked on the patient record form and includes cleaning,
debridement, and dressing of burns; repair of lacerations
with skin tape or sutures; removal of foreign bodies; exci-
sions; and incision and drainage of wounds provided at the
visit. Physician office and outpatient department forms
have space to write in ambulatory surgical procedures.
ICD-9-CM procedure codes were combined to describe
the surgical management of skin and soft tissue infections.
Statistical Analyses
NAMCS and NHAMCS data were weighted to produce
national estimates, and data were combined in 2 groups of
3 years each (1992–1994 and 2001–2003) to provide more
reliable estimates. The NAMCS weight includes 4 compo-
nents: selection probability, nonresponse adjustment,
physician-population weighting ratio adjustment, and
weight smoothing. Starting with 2001 data, the adjustment
for NAMCS physicians who did not provide patient record
forms differs from the adjustment used in prior years by
taking into account additional characteristics of the physi-
cian’s practice. Previously, these characteristics were
assumed to be the same for physicians who provided infor-
mation about patient visits and those who did not. The
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ability, nonresponse adjustment, and ratio adjustment to
fixed totals. SUDAAN statistical software was used for all
statistical analyses (19).
The determination of statistical significance was based
on the 2-tailed t test (0.05 level of significance). The
Bonferroni inequality was used to establish the critical
value for statistically significant differences based on the
number of possible comparisons within a particular vari-
able (or combination of variables) of interest. Terms relat-
ing to differences such as “greater than” or “less than”
indicate that the difference is statistically significant. The
standard errors used to calculate the 95% confidence inter-
vals (CIs) around the estimates took into account the com-
plex sample designs of the NAMCS and NHAMCS.
Estimates based on <30 cases in the sample data did not
meet standard of reliability or precision and are indicated
in the tables (20).
To determine which factors were independently associ-
ated with a diagnosis of skin and soft tissue infection, a
logistic regression analysis that included all visits was per-
formed. The dependent variable was defined as a diagno-
sis of skin and soft tissue infection. The model contained
the following independent variables: setting type, age, sex,
race, expected source of payment, and geographic region.
Before 2003, NAMCS and NHAMCS were exempt
from Institutional Review Board review. In February 2003,
NAMCS and NHAMCS protocols were approved by
CDC’s National Center for Health Statistics Research
Ethics Review Board. Waivers were granted for the
requirements to obtain informed consent of patients and
patient authorization for release of patient medical record
data by healthcare providers. 
Results
During 2001–2003, a total of 11.6 million annual visits
were made to US ambulatory care providers for selected
skin and soft tissue infections, representing 1.0% (95% CI
0.9–1.1) of all visits; the visit rate was 410.7 per 10,000
persons. A comparison of the 1992–1994 and 2001–2003
visit rates showed no difference in the rates of overall and
physician office visits during the study period; however,
the rates for outpatient and emergency department visits
increased by 59% and 31%, respectively (Figure). Tables 2
and 3 show the visit rates and percentage distributions for
skin and soft tissue infections according to characteristics
of patients, providers, and visits. The proportion of visits
made to physician offices decreased from 1992–1994
through 2001–2003, while the proportion of visits to emer-
gency and outpatient departments increased. More than
half of all visits (56.2%, 95% CI 52.2–60.2) were initial
visits, 33.3% (95% CI 29.6–37.3) were follow-up visits,
and 10.5% (95% CI 7.9–13.7) were of unknown episode.
No differences in visit rates were found according to sex,
Skin and Soft Tissue Infections, Ambulatory Care
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higher for children and adolescents 2–18 years of age than
for persons >65 years of age and were higher for those
residing in the South than those in the Midwest. A greater
proportion of visits were made by female patients and a
higher proportion occurred in the South than in the other 3
regions. Private insurance was the most frequently record-
ed expected source of payment, accounting for half of the
visits. The visit rates for Medicare and Medicaid patients
were higher than for those with private or no insurance.
The proportions of visits made by patients eligible for
Medicaid (23.9%, 95% CI 19.5–29.0) and patients with no
insurance (15.4%, 95% CI 11.8–19.9) were higher for out-
patient departments (14.5%, 95% CI 10.7–19.2) than
physician offices (4.6%, 95% CI 2.8–7.2). When rates for
1992–1994 were compared with rates for 2001–2003, no
differences were observed overall or by age, sex, or race;
however, rates increased in metropolitan statistical areas
and in the South and decreased in the Midwest.
Skin and soft tissue infection visits by diagnosis are dis-
played in Table 1. During 2001–2003, “other cellulitis and
abscess” was diagnosed at 53.2% of visits; the visit rate for
this diagnosis had increased by 26% since 1992–1994. In
contrast, the visit rate for impetigo decreased by 32% dur-
ing the study period.
Approximately 22.0% (95% CI 19.2–25.0) of visits for
skin and soft tissue infection were related to injury.
However, the cause of injury is not linked to diagnosis on
the patient record form. During 2001–2003, the leading
causes of injury were natural and environmental factors
(including insect and animal bites) (22.4%, 95% CI
16.7–29.4), being unintentionally cut or pierced by instru-
ments or objects (10.2%, 95% CI 6.7–15.1), and being
accidentally struck against or struck by objects or persons
(8.4%, 95% CI 5.1–13.5). 
In the emergency department, wound care was provid-
ed at 41.6% (95% CI 36.7–46.7) of visits for injury-relat-
ed skin and soft tissue infection. For injury- and
illness-related skin and soft tissue infection visits, wound
care was provided at 31.3% (95% CI 28.6–34.2) of visits.
In physician office and outpatient department settings, pro-
cedures related to the surgical management of skin and soft
tissue infections were ordered, scheduled, or performed at
9.6% (95% CI 7.3–12.4) of visits.
Antimicrobial drugs were prescribed at 64.6% (95%
CI 60.8–68.2) of visits for skin and soft tissue infections
during 2001–2003. Between 1992–1994 and 2001–2003,
no differences were found in antimicrobial drug prescrib-
ing rates overall or for selected therapeutic subclasses,
except for cephalosporins, which were prescribed at a
higher rate during 2001–2003 and lincosamides/
macrolides, which were prescribed at a higher rate during
1992–1994 (Table 4).
During 2001–2003, of all visits for skin and soft tissue
infections, 4.0% (95% CI 3.0–5.3) resulted in hospital
admission; when limited to visits to the emergency depart-
ment only, the percentage was 13.6% (95% CI 10.5–14.7).
These percentages did not differ from those observed dur-
ing 1992–1994, which were 3.6% (95% CI 2.6–4.7) and
12.6% (95% CI 2.5–14.7), respectively. For all visits for
skin and soft tissue infection, no follow-up was planned
for 7.4% (95% CI 5.6–9.6), and referral to another physi-
cian was made for 14.4% (95% CI 12.4–16.6).
A multivariate model of factors associated with a skin
and soft tissue infection diagnosis for 2001–2003 showed
independent associations for the following: emergency
department setting, male sex, payment by Medicaid, and
residence in the South and West (Table 5). The results from
the overall model were significant (p<0.001).
Discussion
We estimate 11.6 million ambulatory healthcare visits
for skin and soft tissue infections possibly due to S. aureus
in the United States each year from 2001 through 2003. No
change in the overall visit rate for skin and soft tissue infec-
tions was found when compared with 1992–1994; howev-
er, an increase in these visit rates was observed in hospital
emergency and outpatient departments, many for infections
coded as cellulitis or abscess. This trend is consistent with
findings from a study conducted in a Los Angeles emer-
gency department, where the prevalence of MRSA among
patients with skin and soft tissue infections rose from 29%
in 2001–2002 to 64% in 2003–2004 (21). These data indi-
cate that the number of S. aureus skin and soft tissue infec-
tions is substantial and that the emergence of CA-MRSA
may affect ambulatory healthcare in the United States.
Although we did not identify the causes of the infections,
the increase in the rate of visits for cellulitis or abscesses
RESEARCH
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Figure. Average rates for annual ambulatory care visits for skin
and soft tissue infections, by setting, United States, 1992–1994
and 2001–2003. p<0.001 for rates for outpatient and emergency
department visits. PO, physician office; OPD, outpatient depart-
ment; ED, emergency department. Error bars indicate 95% confi-
dence intervals.may in part reflect the emergence of CA-MRSA. Many
reports of CA-MRSA skin and soft tissue infections have
been documented in either closed populations with frequent
skin-to-skin contact (22–25) or emergency department
patients and patients admitted through an emergency
department (4,8,25). Published reports have indicated that
CA-MRSA strains, especially those with the Panton-
Valentine leukocidin toxin, are more likely to cause
abscesses with a necrotic center that progress rapidly (6–8).
This rapid progression of lesions, frequently described as
spider bites (26,27), may lead persons to seek care in emer-
gency departments rather than physician offices. Apossible
explanation for the increased visits to outpatient depart-
ments but not physician offices is differences in certain
patient demographic and medical characteristics (28,29).
For all settings during 2001–2003, skin and soft tissue
infections were independently associated with Medicaid
reimbursement relative to private insurance. For all visits
made to emergency and outpatient departments in 2003,
utilization rates were about 4 times higher for Medicaid
recipients than for those with private insurance (28,30);
however, no difference was found for those who visited
physician offices (29). CA-MRSA might disproportion-
ately affect particular socioeconomic groups who are
more likely to seek care in certain settings, which in turn
might increase skin and soft tissue infection visit rates to
some ambulatory care settings (5). However, this finding
does not mean that visit rates to other ambulatory care
settings will not increase as CA-MRSA continues to
emerge.
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the demographic groups at greatest risk for skin and soft
tissue infections likely caused by S. aureus are patients
who are male, reside in the South or West, and receive
Medicaid. In contrast to the age groups affected by most
health conditions, the oldest age groups are at lower risk.
Because of the contagious nature of S. aureus strains
responsible for skin and soft tissue infection, younger men
who have skin-to-skin contact, such as those who play on
athletic teams, may be more likely to acquire the infection
(23,24). The association with certain geographic regions
may reflect the distribution of demographic groups at high-
est risk or, alternatively, climate factors (e.g., higher heat
and humidity) conducive to skin and soft tissue infections.
As CA-MRSA continues to emerge, monitoring its
effect on therapy and whether clinicians are responding
appropriately will be helpful. For abscesses, incision and
drainage constitute the most important form of primary
therapy (31,32). For >30% of all visits to emergency
departments and 10% of visits to outpatient departments
and physician offices, wound care, which could include
incision and drainage, was provided. Logically, provision
of wound care would be higher in emergency departments
than in physician offices or outpatient departments, given
that patients with more severe infections are generally
referred to this setting. However, another explanation of
the difference in the 3 settings may be manner of data col-
lection. In the emergency department, wound care is indi-
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procedure is written in. Write-in items generally have a
higher nonresponse rate than check-box items (33).
With the continued emergence of CA-MRSA, the clin-
ical management of skin and soft tissue infections has now
returned to the basic principles of surgical drainage and
debulking, wound culture, and the use of older antimicro-
bial agents other than β-lactams (34). However, our results
indicate that β-lactam drugs consisting of cephalosporins
and penicillins remain the most commonly prescribed ther-
apy for skin and soft tissue infections and that the rate of
use of cephalosporins increased over the 12-year study
period. A recent study found that for 57% of patients seen
in emergency departments for skin and soft tissue infec-
tions associated with MRSA, the infecting isolate was
resistant to the agent prescribed (4). Before the emergence
of CA-MRSA, the most appropriate form of antimicrobial
therapy for skin and soft tissue infection was β-lactams
(assuming penicillins consisted of antistaphylococcal
agents). Now clinicians must take into account local and
regional rates of CA-MRSAand consider the use of agents
such as clindamycin (a lincosamide) or trimethoprim-sul-
famethoxazole in the empiric treatment of skin and soft tis-
sue infections (32). Periodic monitoring of antimicrobial
drug use may be helpful as CA-MRSA continues to
emerge.
Our study has several limitations. Most important is the
fact that these ICD-9-CM codes have not been validated as
a method for tracking skin and soft tissue infections likely
to be caused by S. aureus, much less infections caused by
CA-MRSA. In addition, whether the baseline risks for skin
and soft tissue infections were similar between the 2 peri-
ods studied is unknown. Rates for conditions such as dia-
betes, peripheral vascular disease, traumatic injuries, and
homelessness might differ for the 2 periods, which would
obscure any actual increase in skin infections due to
MRSA. Although 3 years of data were combined, some
estimates were not presented because they were unreliable,
and some estimates for diagnoses, drugs, and procedures
were aggregated into broader categories to attain reliabili-
ty. Because the design of NAMCS and NHAMCS does not
allow for patient follow-up, some cases may have been
counted multiple times. Because diagnosis cannot be asso-
ciated with a particular drug, we could only assume that
the antimicrobial drug listed was prescribed for the skin or
soft tissue infection diagnosis recorded at the same visit.
Procedure data are collected differently in emergency
departments than in physician offices and hospital
outpatient departments and, therefore, are not comparable.
Skin and soft tissue infections misdiagnosed as spider bites
Skin and Soft Tissue Infections, Ambulatory Care
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found that the rate for all visits assigned a cause-of-injury
E-code of 905.1 (venomous spiders) increased significant-
ly, from 2.7 per 10,000 persons (95% CI 1.5–3.9) during
1992–1994 to 8.4 (95% CI 4.9–11.9) during 2001–2003.
In conclusion, we found that the number of skin and
soft tissue infections is increasing in hospital emergency
and outpatient departments; this increase may reflect the
emergence of CA-MRSA. However, despite these increas-
es, changes in the therapeutic approach to these infections
are not apparent. These findings may serve as a baseline
for future analyses to track the continued emergence and
effect of CA-MRSAon ambulatory healthcare and to mon-
itor how clinicians adapt and treat these patients.
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